Ilona-Petra Maser

Company: iOmx Therapeutics

Job title: Senior Scientist & Group Leader

Seminars:

OMX-0407 a Spectrum Selective Kinase Inhibitor Shows Preclinical & Clinical Efficacy in Angiosarcoma 4:30 pm

Demonstrating striking anti-tumour efficacy in a rare indication PDX of an Angiosarcoma with a comprehensive mode of action analysis Translating research into the first clinical findings with one responder patient in a Ph1a studyRead more

day: Conference Day 1